Under item 4, we will take evidence on the National Health Service (Pharmaceutical Services) (Scotland) (Miscellaneous Amendments) Regulations 2014 (SSI 2014/148). It should be said that it is slightly unusual to take evidence on a negative instrument but because, as everyone would agree, there has been a fair bit of interest in this issue, I thought that it would be useful to invite Scottish Government officials along to answer any questions that members might have.
We have with us this morning a panel of witnesses from the Scottish Government: Professor Bill Scott, chief pharmaceutical officer and deputy director, finance, e-health and pharmaceuticals directorate; David Thomson, deputy director, primary care division; and Katy Richards—still with us from earlier—who is a solicitor in the food, health and community care division.
We will go straight to members’ questions.
